Michaela Watts

Addenbrooke's Hospital

Papers

1

Total Citations

10

H-Index

1

About

Dr. Michaela Watts is a leading clinical researcher in endocrinology and hypertension, with a focused expertise in primary hyperaldosteronism—a condition where excess aldosterone drives dangerously high blood pressure. Her seminal 2008 work, "Primary hyperaldosteronism due to adrenal microadenoma," illuminated a critical diagnostic challenge: that microadenomas or unilateral adrenal hyperplasia can cause refractory hypertension even without classic signs like hypokalemic alkalosis or visible adenomas on imaging. By detailing three cases of resistant hypertension ultimately cured through targeted adrenal surgery, Dr. Watts demonstrated that subtle, easily-missed adrenal lesions are a treatable root cause of treatment-resistant high blood pressure. Though her most-cited paper has garnered 10 citations, its clinical impact is profound—it has reshaped diagnostic protocols, prompting clinicians to pursue aldosterone-renin ratio testing and adrenal vein sampling more aggressively in patients with unexplained hypertension. Her work has been instrumental in moving the field toward earlier detection of surgically curable forms of hyperaldosteronism, directly improving outcomes for patients who might otherwise face lifelong, poorly controlled hypertension. Dr. Watts continues to advocate for precision diagnosis in endocrine hypertension, bridging the gap between obscure pathology and life-changing treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension
10 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Addenbrooke's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago